Elevated serum interleukin‐6 (IL‐6) is derived from neoplastic lymphoid cells in patients with B‐cell non‐Hodgkin's lymphoma: correlation with extent of IL‐6 expression and serum concentration

We investigated the expression of interleukin‐6 (IL‐6) mRNA in tumours from 21 patients with B‐cell non‐Hodgkin's lymphoma (NHL). Total RNA, extracted from diagnostic tissue specimens, was subjected to semi‐quantitative analysis for IL‐6 mRNA by the reverse transcription‐polymerase chain reaction (RT‐PCR). The amount of IL‐6 mRNA was semi‐quantified against that in pokeweed mitogen (PWM) stimulated peripheral blood mononuclear cells. The expression of IL‐6 in neoplastic B cells was confirmed by immunohistochemistry. We then looked for correlations between the amount of IL‐6 mRNA produced by neoplastic B cells and serum IL‐6 concentrations. The amount of IL‐6 mRNA correlated with the circulating IL‐6 concentration, suggesting that the malignant cells were the source of IL‐6 in these patients with B‐cell NHL. Our results suggest that the circulating IL‐6 in patients with B‐cell NHL is derived from the neoplastic lymphoid cells, and that neoplastic cells may act as modulators of the general status of patients with B‐cell NHL.

[1]  R. Kurzrock,et al.  Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Blay,et al.  Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. , 1994, Blood.

[3]  S. Pileri,et al.  Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease cases , 1993, British journal of haematology.

[4]  R. Kurzrock,et al.  Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. , 1993, Cancer research.

[5]  C. Gisselbrecht,et al.  Interleukin-6 production in high-grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. , 1992, Blood.

[6]  R. Willemze,et al.  Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells , 1992, The Journal of experimental medicine.

[7]  C. von Kalle,et al.  Expression of interleukin-6 and interleukin-6 receptor in Hodgkin's disease. , 1991, Blood.

[8]  T. Nakahata,et al.  Spontaneous production of interleukin-6 by Ki-1-positive large-cell anaplastic lymphoma with extensive bone destruction. , 1991, Blood.

[9]  Y. Kagami,et al.  Interleukin 4 and γ-Interferon May Play a Role in the Histopathogenesis of Peripheral T-Cell Lymphoma , 1990 .

[10]  J. Gardner,et al.  Effects of interleukin-6 on fetal hematopoietic progenitors. , 1990, Blood.

[11]  S. Matsumoto,et al.  The inductive effect of interleukin‐4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes , 1990, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[12]  P. Sehgal,et al.  Interleukin-6 immunoreactivity in human tumors. , 1989, The American journal of pathology.

[13]  X. H. Wang,et al.  A possible autocrine role for interleukin-6 in two lymphoma cell lines. , 1989, Blood.

[14]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[15]  T. Sugimura,et al.  Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Rennick,et al.  Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells. , 1989, Blood.

[17]  G. Freeman,et al.  Interleukin 6 gene expression in normal and neoplastic B cells. , 1989, The Journal of clinical investigation.

[18]  D. Caracciolo,et al.  Human interleukin-6 supports granulocytic differentiation of hematopoietic progenitor cells and acts synergistically with GM-CSF. , 1989, Blood.

[19]  M. Jourdan,et al.  Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. , 1989, Blood.

[20]  T. Hirano,et al.  Interleukin-6 (B-cell stimulatory factor 2)-dependent growth of a Lennert's lymphoma-derived T-cell line (KT-3). , 1988, Blood.

[21]  A. Okano,et al.  Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture , 1988, The Journal of experimental medicine.

[22]  V. Paetkau,et al.  The role of IL-5 in IgA B cell differentiation. , 1988, Journal of immunology.

[23]  H. Asaoku,et al.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.

[24]  A Muraguchi,et al.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells , 1988, The Journal of experimental medicine.

[25]  P. Lansdorp,et al.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[27]  T. Komori,et al.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. , 1989, Blood.

[28]  W. Paul,et al.  B-cell stimulatory factor-1/interleukin 4. , 1987, Annual review of immunology.